BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29161980)

  • 1. Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.
    Aref S; Azmy E; El-Bakry K; Ibrahim L; Mabed M
    Hematology; 2018 Jun; 23(5):263-270. PubMed ID: 29161980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.
    Aref S; Azmy E; El-Bakry K; Ibrahim L; Abdel Aziz S
    Pediatr Hematol Oncol; 2017 Aug; 34(5):275-285. PubMed ID: 29144828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
    Aref S; Abousamra N; El-Helaly E; Mabed M
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of bone marrow CD56
    Theodorakos I; Paterakis G; Papadakis V; Vicha A; Topakas G; Jencova P; Karchilaki E; Taparkou A; Tsagarakis NJ; Polychronopoulou S
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27799. PubMed ID: 31066205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
    Damiani D; Tiribelli M; Raspadori D; Sirianni S; Meneghel A; Cavalllin M; Michelutti A; Toffoletti E; Geromin A; Simeone E; Bocchia M; Fanin R
    Oncotarget; 2015 Oct; 6(30):30212-21. PubMed ID: 26338961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric B-lineage Acute Lymphoblastic Leukemia With CD56 Expression: A Report of 2 Cases.
    Aoki M; Kobayashi K; Taji Y; Shimizu Y; Ohta A; Watanabe A; Fukushima T; Tanaka R; Ebihara Y
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):249-250. PubMed ID: 31876778
    [No Abstract]   [Full Text] [Related]  

  • 7. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.
    Ghazavi F; Clappier E; Lammens T; Suciu S; Caye A; Zegrari S; Bakkus M; Grardel N; Benoit Y; Bertrand Y; Minckes O; Costa V; Ferster A; Mazingue F; Plat G; Plouvier E; Poirée M; Uyttebroeck A; van der Werff-Ten Bosch J; Yakouben K; Helsmoortel H; Meul M; Van Roy N; Philippé J; Speleman F; Cavé H; Van Vlierberghe P; De Moerloose B
    Haematologica; 2015 Oct; 100(10):1311-9. PubMed ID: 26137961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
    Tiribelli M; Raspadori D; Geromin A; Cavallin M; Sirianni S; Simeone E; Bocchia M; Fanin R; Damiani D
    Leuk Res; 2017 Jul; 58():31-38. PubMed ID: 28407515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.
    Alapat D; Coviello-Malle J; Owens R; Qu P; Barlogie B; Shaughnessy JD; Lorsbach RB
    Am J Clin Pathol; 2012 Jan; 137(1):93-100. PubMed ID: 22180482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic Leukemia.
    Adnan Awad S; Kamel MM; Ayoub MA; Kamel AM; Elnoshokaty EH; El Hifnawi N
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S19-S24.e1. PubMed ID: 27521317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.
    Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T
    Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
    Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
    Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
    Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
    Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between Expression of CD200 and Regulatory T Cells in Multiple Myeloma and Its Significance in Prognostic Stratification].
    Zhu MX; Wan WL; Li HS; Wang YF; Wang J; Ling HS; Yan XX; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1427-1432. PubMed ID: 27784369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
    Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center.
    Tiribelli M; Michelutti A; Cavallin M; Di Giusto S; Fanin R; Damiani D
    Turk J Haematol; 2021 Jun; 38(2):119-125. PubMed ID: 33596632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.
    Bohling SD; Davis E; Thompson K; Kussick SJ; Love J
    Cytometry B Clin Cytom; 2016 Nov; 90(6):493-498. PubMed ID: 26584149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.